CLINICAL_TRIALS
trial_result
· 2021-04-12
Clinical Trial Update: A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia [Phase 3]
Summary
Phase 3 study evaluating transition from zolpidem to lemborexant for insomnia has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Insomnia | Phase 3 | Status: COMPLETED | Results posted: 2021-04-12